CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
This Quarter Return
+6.6%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$729M
AUM Growth
+$729M
(+8.4%)
Cap. Flow
+$68.4M
Cap. Flow
% of AUM
9.39%
Top 10 Holdings %
Top 10 Hldgs %
68%
Holding
32
New
8
Increased
10
Reduced
8
Closed
6
Top Buys
| 1 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
$44.6M |
| 2 |
United Therapeutics
UTHR
|
$43.1M |
| 3 |
AKRX
Akorn, Inc.
AKRX
|
$24M |
| 4 |
RLYP
RELYPSA INC COM
RLYP
|
$13.9M |
| 5 |
Travere Therapeutics
TVTX
|
$13.9M |
Top Sells
| 1 |
WX
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
|
$37.6M |
| 2 |
IPCM
IPC HEALTHCARE INC COM DTD
IPCM
|
$25.3M |
| 3 |
Myriad Genetics
MYGN
|
$19.8M |
| 4 |
Supernus Pharmaceuticals
SUPN
|
$15.8M |
| 5 |
TARO
Taro Pharmaceutical Industries Ltd.
TARO
|
$10.3M |
Sector Composition
| 1 | Healthcare | 69.06% |
| 2 | Industrials | 2.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
HealthStream
HSTM
$832M
| $4.17M | 0.57% |
+173,833
| New | +$4.17M |
|
|
AVDL
27
Avadel Pharmaceuticals
AVDL
$1.45B
| – | – |
-630,178
| Closed | -$9.45M |
|
|
28
Myriad Genetics
MYGN
$642M
| – | – |
-507,682
| Closed | -$19.8M |
|
|
29
Supernus Pharmaceuticals
SUPN
$2.5B
| – | – |
-1,440,008
| Closed | -$15.8M |
|
|
WX
30
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
| – | – |
-1,143,315
| Closed | -$37.6M |
|
|
IPCM
31
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
| – | – |
-573,209
| Closed | -$25.3M |
|
|
FURX
32
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
| – | – |
-13,440
| Closed | -$1.43M |
|